Log in with your NetID to export as a spreadsheet. After you log in, you will need to re-select any search options you've chosen.
| Deadline | Title |
Funding Agency |
Discipline | Who's Eligible | Award Amount | Date Posted |
|---|---|---|---|---|---|---|
| Deadline: 10/05/2021 | Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 2/05/2023 | Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 10/31/2022 |
| Deadline: 7/26/2019 | Notice of Intent to Publish Funding Opportunity Announcements for Phase 2 of the U.S.-South Africa Program for Collaborative Biomedical Research (R01 and U01, Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 2/05/2023 | Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/21/2022 |
| Deadline: 10/23/2019 | Oscillatory Patterns of Gene Expression in Aging and Alzheimer’s Disease (R01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $3,000,000 | 4/18/2022 |
| Deadline: 10/23/2019 | Interpersonal Processes in Alzheimer's Disease and Related Dementias Clinical Interactions and Care Partnerships (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $2,500,000 | 4/18/2022 |
| Deadline: 3/30/2022 | U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trials Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 2/05/2023 | Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 11/21/2022 |
| Deadline: 10/22/2019 | The NINDS Human Cell and Data Repository (U24 - Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $4,250,000 | 4/18/2022 |
| Deadline: 11/29/2019 | Women's Reproductive Health Research (WRHR) Career Development Program (K12)(Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $1,575,000 | 4/18/2022 |
| Deadline: 3/18/2020 | Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 4/18/2022 |
| Deadline: 1/17/2020 | Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $3,750,000 | 4/18/2022 |
| Deadline: 4/03/2020 | Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $6,500,000 | 4/18/2022 |
| Deadline: 12/01/2022 | Contraceptive Development Research Center (P50 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 8/02/2022 |
| Deadline: 5/29/2020 | Three-Dimensional (3D) Human Biomimetics for Infectious Diseases (U19 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $5,000,000 | 4/18/2022 |
| Deadline: 1/07/2022 | Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 7/28/2020 | Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 2/16/2021 | Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 6/24/2021 | Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $1,250,000 | 4/18/2022 |
| Deadline: 10/15/2020 | U.S. - India Collaborative Environmental Health Research Program (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $1,000,000 | 4/18/2022 |
